Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 114.20
-0.80 (-0.70%)
Jun 17, 2025, 11:57 AM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.90 billion as of June 17, 2025. Its market cap has increased by 13.44% in one year.
Market Cap
1.90B
Enterprise Value
1.85B
Revenue
221.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
114.20
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.90B, an increase of 40.83%. That is a compound annual growth rate of 10.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 1.90B | -2.69% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 97.89B |
| Sectra AB | 60.46B |
| Getinge AB | 50.31B |
| Asker Healthcare Group AB | 41.61B |
| Medicover AB | 36.16B |
| Camurus AB | 35.89B |
| AddLife AB | 24.19B |
| Vimian Group AB | 20.64B |